| |
| Xpention
Genetics, Inc. is
a biotechnology company that was formed to develop both immunological
and molecular tests for cancer detection in animals and humans
as well as therapeutic vaccines and other treatment methods
for both veterinary and human cancers. Xpention through its
subsidiary has licensed, exclusive rights to a specific genetic
marker called the p65 that has highly specific correlation
to numerous cancers. |
| |
 |
|
|
|
|
| |
| |
|
|
| |
| Patent
and Technolgy License Agreement |
| |
| Xpention Genetics, through
its wholly owned subsidiary Xpention Inc., has entered into
a Patent and Technology License Agreement with The University of
Texas M.D. Anderson Cancer Center which grants Xpention the exclusive
right to patented technology for the detection of cancer based
on a tumor marker known as p65 which has been demonstrated to have
elevated levels in the blood of canine and human cancer conditions. |
|
